Seres Therapeutics, Inc. revenue breakdown overview

Seres Therapeutics, Inc. revenue for the last year amounted to 126.33 M USD, the most of which — 126.33 M USD — came from its highest performing source at the moment, Microbiome Therapeutics, the year earlier bringing 7.13 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Seres Therapeutics, Inc. 126.33 M USD, and the year before that — 7.13 M USD.